Ignite Creation Date:
2025-12-24 @ 7:54 PM
Ignite Modification Date:
2026-02-22 @ 7:04 AM
Study NCT ID:
NCT04832204
Status:
UNKNOWN
Last Update Posted:
2021-04-05
First Post:
2021-04-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Apatinib Combined With SHR-1210 as Second-line Treatment in Solid Tumors With Only Liver Metastases
Sponsor:
Beijing Hospital
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
BeijingHY2020-02-07
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |